I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Women's Health | COVID-19 Inpatient | COVID-19 Outpatient
What is the purpose of this trial?
Identify agents that will result in substantial improvements to the clinical condition of participants with COVID-19.
- Ages18 years and older
- Trial withQuantumLeap Healthcare Collaborative
- Start Date10/08/2020
- End Date07/24/2022
- Last Updated07/15/2021
- Study HIC#2000028816